Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity

Cellular and Molecular Life Sciences

Volumn 66, Issue 1, 2009, Pages 43-61

  Berger, W ^a   Steiner, E ^a   Grusch, M ^a   Elbling, L ^a   Micksche, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drug resistance; Immunity; Major vault protein; Signal pathway regulation; Vault particles

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; INTERFERON; JANUS KINASE; LUNG RESISTANCE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN TYROSINE PHOSPHATASE SHP 2; RNA; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TELOMERASE; UBIQUITIN PROTEIN LIGASE COP1;

CANCER RESISTANCE; CELL FUNCTION; DRUG RESISTANCE; HUMAN; IMMUNITY; NONHUMAN; ONCOGENE SRC; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNITY, INNATE; MICE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 58149502680     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8364-z     Document Type: Review

References (157)

1. Kedersha, N. L., and Rome, L. H. (1986) Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J. Cell Biol. 103, 699-709.
2. Kedersha, N. L., Hill, D. F., Kronquist, K. E., and Rome, L. H. (1986) Subpopulations of liver coated vesicles resolved by preparative agarose gel electrophoresis. J. Cell Biol. 103, 287-297.
3. Rome, L., Kedersha, N., and Chugani, D. (1991) Unlocking vaults: organelles in search of a function. Trends Cell Biol. 1, 47-50.
4. Kickhoefer, V. A., Searles, R. P., Kedersha, N. L., Garber, M. E., Johnson, D. L., and Rome, L. H. (1993) Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J. Biol. Chem. 268, 7868-7873.
5. Kickhoefer, V. A., Siva, A. C., Kedersha, N. L., Inman, E. M., Ruland, C., Streuli, M., and Rome, L. H. (1999) The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J. Cell Biol. 146, 917-928.
6. Kickhoefer, V. A., Stephen, A. G., Harrington, L., Robinson, M. O., and Rome, L. H. (1999) Vaults and telomerase share a common subunit, TEP1. J. Biol. Chem. 274, 32712-32717.
7. Kedersha, N. L., Heuser, J. E., Chugani, D. C., and Rome, L. H. (1991) Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J. Cell Biol. 112, 225-235.
8. Kong, L. B., Siva, A. C., Rome, L. H., and Stewart, P. L. (1999) Structure of the vault, a ubiquitous celular component. Structure Fold Des. 7, 371-379.
9. Mikyas, Y., Makabi, M., Raval-Fernandes, S., Harrington, L., Kickhoefer, V. A., Rome, L. H., and Stewart, P. L. (2004) Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP. J. Mol. Biol. 344, 91-105.
10. Kozlov, G., Vavelyuk, O., Minailiuc, O., Banville, D., Gehring, K., and Ekiel, I. (2006) Solution structure of a two-repeat fragment of major vault protein. J. Mol. Biol. 356, 444-452.
11. Kong, L. B., Siva, A. C., Kickhoefer, V. A., Rome, L. H., and Stewart, P. L. (2000) RNA location and modeling of a WD40 repeat domain within the vault. Rna 6, 890-900.
12. Kato, K., Tanaka, H., Sumizawa, T., Yoshimura, M., Yamashita, E., Iwasaki, K., and Tsukihara, T. (2008) A vault ribonucleoprotein particle exhibiting 39-fold dihedral symmetry. Acta Crystallogr. D. Biol. Crystallogr. 64, 525-531.
13. Herrmann, C., Zimmermann, H., and Volknandt, W. (1997) Analysis of a cDNA encoding the major vault protein from the electric ray Discopyge ommata. Gene 188, 85-90.
14. Kedersha, N. L., Miquel, M. C., Bittner, D., and Rome, L. H. (1990) Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J. Cell Biol. 110, 895-901.
15. Mossink, M., van Zon, A., Franzel-Luiten, E., Schoester, M., Scheffer, G. L., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2002) The genomic sequence of the murine major vault protein and its promoter. Gene 294, 225-232.
16. Mossink, M. H., van Zon, A., Scheper, R. J., Sonneveld, P., Wiemer, E. A., Schoester, M., Houtsmuller, A. B., Scheffer, G. L., Franzel-Luiten, E., Kickhoefer, V. A., Mossink, M., Poderycki, M. J., Chan, E. K., and Rome, L. H. (2003) Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22, 7458-7467.
17. Suprenant, K. A. (2002) Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry 41, 14447-14454.
18. Vasu, S. K., Kedersha, N. L., and Rome, L. H. (1993) cDNA cloning and disruption of the major vault protein alpha gene (mvpA) in Dictyostelium discoideum. J. Biol. Chem. 268, 15356-15360.
19. Suprenant, K. A., Bloom, N., Fang, J., and Lushington, G. (2007) The major vault protein is related to the toxic anion resistance protein (TelA) family. J. Exp. Biol. 210, 946-955.
20. Kickhoefer, V. A., Vasu, S. K., and Rome, L. H. (1996) Vaults are the answer, what is the question? Trends Cell Biol. 6, 174-178.
21. van Zon, A., Mossink, M. H., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2003) The vault complex. Cell. Mol. Life Sci. 60, 1828-1837.
22. Anderson, D. H., Kickhoefer, V. A., Sievers, S. A., Rome, L. H., and Eisenberg, D. (2007) Draft crystal structure of the vault shell at 9-A resolution. PLoS Biol. 5, e318.
23. Kedersha, N. L., and Rome, L. H. (1990) Vaults: large cytoplasmic RNP's that associate with cytoskeletal elements. Mol. Biol. Rep. 14, 121-122.
24. Stephen, A. G., Raval-Fernandes, S., Huynh, T., Torres, M., Kickhoefer, V. A., and Rome, L. H. (2001) Assembly of vault-like particles in insect cells expressing only the major vault protein. J. Biol. Chem. 276, 23217-23220.
25. Poderycki, M. J., Kickhoefer, V. A., Kaddis, C. S., Raval-Fernandes, S., Johansson, E., Zink, J. I., Loo, J. A., and Rome, L. H. (2006) The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry 45, 12184-12193.
26. Kickhoefer, V. A., Garcia, Y., Mikyas, Y., Johansson, E., Zhou, J. C., Raval-Fernandes, S., Minoofar, P., Zink, J. I., Dunn, B., Stewart, P. L., and Rome, L. H. (2005) Engineering of vault nanocapsules with enzymatic and fluorescent properties. Proc. Natl. Acad. Sci. U S A 7, 7.
27. van Zon, A., Mossink, M. H., Schoester, M., Scheffer, G. L., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2002) Structural domains of vault proteins: a role for the coiled coil domain in vault assembly. Biochem. Biophys. Res. Commun. 291, 535-541.
28. Yu, Z., Fotouhi-Ardakani, N., Wu, L., Maoui, M., Wang, S., Banville, D., and Shen, S. H. (2002) PTEN associates with the vault particles in HeLa cells. J. Biol. Chem. 277, 40247-40252.
29. Kickhoefer, V. A., Rajavel, K. S., Scheffer, G. L., Dalton, W. S., Scheper, R. J., and Rome, L. H. (1998) Vaults are upregulated in multidrug-resistant cancer cell lines. J. Biol. Chem. 273, 8971-8974.
30. Hamill, D. R., and Suprenant, K. A. (1997) Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport. Dev. Biol. 190, 117-128.
31. Izquierdo, M. A., Scheffer, G. L., Flens, M. J., Shoemaker, R. H., Rome, L. H., and Scheper, R. J. (1996) Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology 19, 191-197.
32. Scheffer, G. L., Schroeijers, A. B., Izquierdo, M. A., Wiemer, E. A., and Scheper, R. J. (2000) Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr. Opin. Oncol. 12, 550-556.
33. Scheper, R. J., Broxterman, H. J., Scheffer, G. L., Kaaijk, P., Dalton, W. S., van Heijningen, T. H., van Kalken, C. K., Slovak, M. L., de Vries, E. G., van der Valk, P., and et al. (1993) Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53, 1475-1479.
34. Steiner, E., Holzmann, K., Elbling, L., Micksche, M., and Berger, W. (2006) Cellular functions of vaults and their involvement in multidrug resistance. Curr. Drug Targets 7, 923-934.
35. Berger, W., Spiegl-Kreinecker, S., Buchroithner, J., Elbling, L., Pirker, C., Fischer, J., and Micksche, M. (2001) Overexpression of the human major vault protein in astrocytic brain tumor cells. Int. J. Cancer 94, 377-382.
36. Meijer, G. A., Schroeijers, A. B., Flens, M. J., Meuwissen, S. G., van der Valk, P., Baak, J. P., and Scheper, R. J. (1999) Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis. J. Clin. Pathol. 52, 450-454.
37. Zurita, A. J., Diestra, J. E., Condom, E., Garcia Del Muro, X., Scheffer, G. L., Scheper, R. J., Perez, J., Germa-Lluch, J. R., and Izquierdo, M. A. (2003) Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours. Br. J. Cancer 88, 879-886.
38. Ryu, S. J., An, H. J., Oh, Y. S., Choi, H. R., Ha, M. K., and Park, S. C. (2008) On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis. Cell Death Differ. doi: 10.1038/cdd.2008.96.
39. Stein, U., Jurchott, K., Schlafke, M., and Hohenberger, P. (2002) Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients. J. Clin. Oncol. 20, 3282-3292.
40. Abbondanza, C., Rossi, V., Roscigno, A., Gallo, L., Belsito, A., Piluso, G., Medici, N., Nigro, V., Molinari, A. M., Moncharmont, B., and Puca, G. A. (1998) Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell. J. Cell Biol. 141, 1301-1310.
41. Berger, W., Elbling, L., and Micksche, M. (2000) Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int. J. Cancer 88, 293-300.
42. Emre, N., Raval-Fernandes, S., Kickhoefer, V. A., and Rome, L. H. (2004) Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP. Biochim. Biophys. Acta 1678, 33-46.
43. Stein, U., Bergmann, S., Scheffer, G. L., Scheper, R. J., Royer, H. D., Schlag, P. M., and Walther, W. (2005) YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene. Oncogene 7, 7.
44. Steiner, E., Holzmann, K., Pirker, C., Elbling, L., Micksche, M., and Berger, W. (2004) SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. Biochem. Biophys. Res. Commun. 317, 235-243.
45. Shimamoto, Y., Sumizawa, T., Haraguchi, M., Gotanda, T., Jueng, H. C., Furukawa, T., Sakata, R., and Akiyama, S. (2006) Direct activation of the human major vault protein gene by DNA-damaging agents. Oncol. Rep. 15, 645-652.
46. Hu, Y., Stephen, A. G., Cao, J., Tanzer, L. R., Slapak, C. A., Harrison, S. D., Devanarayan, V., Dantzig, A. H., Starling, J. J., Rome, L. H., and Moore, R. E. (2002) A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. Int. J. Cancer 97, 149-156.
47. Miracco, C., Maellaro, E., Pacenti, L., Del Bello, B., Valentini, M. A., Rubegni, P., Pirtoli, L., Volpi, C., Santopietro, R., and Tosi, P. (2003) Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. Int. J. Oncol. 23, 213-220.
48. Steiner, E., Holzmann, K., Pirker, C., Elbling, L., Micksche, M., Sutterluty, H., and Berger, W. (2006) The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. J. Cell Sci. 119, 459-469.
49. Stein, U., Walther, W., Laurencot, C. M., Scheffer, G. L., Scheper, R. J., and Shoemaker, R. H. (1997) Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. J. Natl. Cancer Inst. 89, 807-813.
50. Knutsen, T., Rao, V. K., Ried, T., Mickley, L., Schneider, E., Miyake, K., Ghadimi, B. M., Padilla-Nash, H., Pack, S., Greenberger, L., Cowan, K., Dean, M., Fojo, T., and Bates, S. (2000) Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer 27, 110-116.
51. Rao, V. K., Wangsa, D., Robey, R. W., Huff, L., Honjo, Y., Hung, J., Knutsen, T., Ried, T., and Bates, S. E. (2005) Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells. Cancer Genet. Cytogenet. 160, 126-133.
52. Van der Bliek, A. M., Baas, F., Van der Velde-Koerts, T., Biedler, J. L., Meyers, M. B., Ozols, R. F., Hamilton, T. C., Joenje, H., and Borst, P. (1988) Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 48, 5927-5932.
53. Slovak, M. L., Ho, J. P., Cole, S. P., Deeley, R. G., Greenberger, L., de Vries, E. G., Broxterman, H. J., Scheffer, G. L., and Scheper, R. J. (1995) The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res. 55, 4214-4219.
54. Laurencot, C. M., Scheffer, G. L., Scheper, R. J., and Shoemaker, R. H. (1997) Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int. J. Cancer 72, 1021-1026.
55. Scheffer, G. L., Wijngaard, P. L., Flens, M. J., Izquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijer, C. J., Clevers, H. C., and Scheper, R. J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nat. Med. 1, 578-582.
56. Plaat, B. E., Molenaar, W. M., Sagrudny, J., Bohle, R. M., Mastik, M. F., Hoekstra, H. J., Van der Graaf, W. T., Hollema, H., and van den Berg, E. (2000) The 16p11 breakpoint in myxoid liposarcomas might affect the expression of the LRP gene on 16p11.2 encoding the multidrug resistance associated major vault protein. Eur. J. Clin. Invest. 30, 447-453.
57. Lange, C., Walther, W., Schwabe, H., and Stein, U. (2000) Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem. Biophys. Res. Commun. 278, 125-133.
58. Fujii, T., Kawahara, A., Basaki, Y., Hattori, S., Nakashima, K., Nakano, K., Shirouzu, K., Kohno, K., Yanagawa, T., Yamana, H., Nishio, K., Ono, M., Kuwano, M., and Kage, M. (2008) Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers. Cancer Res. 68, 1504-1512.
59. Oda, Y., Ohishi, Y., Basaki, Y., Kobayashi, H., Hirakawa, T., Wake, N., Ono, M., Nishio, K., Kuwano, M., and Tsuneyoshi, M. (2007) Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci. 98, 1020-1026.
60. Holzmann, K., Ambrosch, I., Elbling, L., Micksche, M., and Berger, W. (2001) A small upstream open reading frame causes inhibition of human major vault protein expression from a ubiquitous mRNA splice variant. FEBS Lett. 494, 99-104.
61. Zheng, C. L., Sumizawa, T., Che, X. F., Tsuyama, S., Furukawa, T., Haraguchi, M., Gao, H., Gotanda, T., Jueng, H. C., Murata, F., and Akiyama, S. (2004) Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. Biochem. Biophys. Res. Commun. 326, 100-107.
62. Sutovsky, P., Manandhar, G., Laurincik, J., Letko, J., Caamano, J. N., Day, B. N., Lai, L., Prather, R. S., Sharpe-Timms, K. L., Zimmer, R., and Sutovsky, M. (2005) Expression and proteasomal degradation of the major vault protein (MVP) in mammalian oocytes and zygotes. Reproduction 129, 269-282.
63. Yi, C., Li, S., Chen, X., Wiemer, E. A., Wang, J., Wei, N., and Deng, X. W. (2005) Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res. 65, 5835-5840.
64. Yi, C., and Deng, X. W. (2005) COP1 - from plant photomorphogenesis to mammalian tumorigenesis. Trends Cell. Biol. 15, 618-625.
65. Ehrnsperger, C., and Volknandt, W. (2001) Major vault protein is a substrate of endogenous protein kinases in CHO and PC12 cells. Biol. Chem. 382, 1463-1471.
66. Herrmann, C., Kellner, R., and Volknandt, W. (1998) Major vault protein of electric ray is a phosphoprotein. Neurochem. Res. 23, 39-46.
67. Kim, E., Lee, S., Mian, M. F., Yun, S. U., Song, M., Yi, K. S., Ryu, S. H., and Suh, P. G. (2006) Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling. Febs J. 273, 793-804.
68. Kolli, S., Zito, C. I., Mossink, M. H., Wiemer, E. A., and Bennett, A. M. (2004) The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 279, 29374-29385.
69. Ame, J. C., Spenlehauer, C., and de Murcia, G. (2004) The PARP superfamily. Bioessays 26, 882-893.
70. Hassa, P. O., and Hottiger, M. O. (2008) The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front. Biosci. 13, 3046-3082.
71. Schreiber, V., Dantzer, F., Ame, J. C., and de Murcia, G. (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7, 517-528.
72. Smith, S. (2001) The world according to PARP. Trends Biochem. Sci. 26, 174-179.
73. Lewis, C., and Low, J. A. (2007) Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer. Curr. Opin. Investig. Drugs 8, 1051-1056.
74. Bateman, A., and Kickhoefer, V. (2003) The TROVE module: A common element in Telomerase, Ro and Vault ribonucleoproteins. BMC Bioinformatics 4, 49.
75. Ame, J. C., Spenlehauer, C., and de Murcia, G. (2004) The PARP superfamily. Bioessays 26, 882-893.
76. Smith, S., and de Lange, T. (2000) Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10, 1299-1302.
77. Liu, Y., Snow, B. E., Kickhoefer, V. A., Erdmann, N., Zhou, W., Wakeham, A., Gomez, M., Rome, L. H., and Harrington, L. (2004) Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol. Cell Biol. 24, 5314-5323.
78. Raval-Fernandes, S., Kickhoefer, V. A., Kitchen, C., and Rome, L. H. (2005) Increased susceptibility of vault poly(-ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis. Cancer Res. 65, 8846-8852.
79. Mossink, M. H., van Zon, A., Franzel-Luiten, E., Schoester, M., Kickhoefer, V. A., Scheffer, G. L., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2002) Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. Cancer Res. 62, 7298-7304.
80. Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Bass, M. B., Arruda, I., and Robinson, M. O. (1997) A mammalian telomerase-associated protein. Science 275, 973-977.
81. Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17, 498-502.
82. Kickhoefer, V. A., Liu, Y., Kong, L. B., Snow, B. E., Stewart, P. L., Harrington, L., and Rome, L. H. (2001) The Telomerase/ vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle. J. Cell Biol. 152, 157-164.
83. Smith, S., and de Lange, T. (2000) Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10, 1299-1302.
84. van Steensel, B., and de Lange, T. (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743.
85. Poderycki, M. J., Rome, L. H., Harrington, L., and Kickhoefer, V. A. (2005) The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle. Nucleic Acids Res. 33, 893-902.
86. Deutscher, S. L., Harley, J. B., and Keene, J. D. (1988) Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc. Natl. Acad. Sci. U S A 85, 9479-9483.
87. Whittaker, C. A., and Hynes, R. O. (2002) Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol. Biol. Cell 13, 3369-3387.
88. Suganuma, T., Pattenden, S. G., and Workman, J. L. (2008) Diverse functions of WD40 repeat proteins in histone recognition. Genes Dev. 22, 1265-1268.
89. Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) The 2.0 A crystal structure of a heterotrimeric G protein. Nature 379, 311-319.
90. van Zon, A., Mossink, M. H., Schoester, M., Scheffer, G. L., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2001) Multiple human vault RNAs. Expression and association with the vault complex. J. Biol. Chem. 276, 37715-37721.
91. Mrazek, J., Kreutmayer, S. B., Grasser, F. A., Polacek, N., and Huttenhofer, A. (2007) Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res. 35, e73.
92. Kickhoefer, V. A., Emre, N., Stephen, A. G., Poderycki, M. J., and Rome, L. H. (2003) Identification of conserved vault RNA expression elements and a non-expressed mouse vault RNA gene. Gene 309, 65-70.
93. Vilalta, A., Kickhoefer, V. A., Rome, L. H., and Johnson, D. L. (1994) The rat vault RNA gene contains a unique RNA polymerase III promoter composed of both external and internal elements that function synergistically. J. Biol. Chem. 269, 29752-29759.
94. Motsch, N., Pfuhl, T., Mrazek, J., Barth, S., and Grasser, F. A. (2007) Epstein-Barr Virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4, 131-137.
95. Kickhoefer, V. A., Poderycki, M. J., Chan, E. K., and Rome, L. H. (2002) The La RNA-binding protein interacts with the vault RNA and is a vault-associated protein. J. Biol. Chem. 277, 41282-41286.
96. Maraia, R. J., and Bayfield, M. A. (2006) The La protein-RNA complex surfaces. Mol Cell 21, 149-152.
97. Goldsmith, L. E., Yu, M., Rome, L. H., and Monbouquette, H. G. (2007) Vault nanocapsule dissociation into halves triggered at low pH. Biochemistry 46, 2865-2875.
98. Slesina, M., Inman, E. M., Moore, A. E., Goldhaber, J. I., Rome, L. H., and Volknandt, W. (2006) Movement of vault particles visualized by GFP-tagged major vault protein. Cell Tissue Res. 324, 403-410.
99. Slesina, M., Inman, E. M., Rome, L. H., and Volknandt, W. (2005) Nuclear localization of the major vault protein in U373 cells. Cell Tissue Res. 321, 97-104.
100. van Zon, A., Mossink, M. H., Houtsmuller, A. B., Schoester, M., Scheffer, G. L., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2006) Vault mobility depends in part on microtubules and vaults can be recruited to the nuclear envelope. Exp. Cell Res. 312, 245-255.
101. van Zon, A., Mossink, M. H., Schoester, M., Houtsmuller, A. B., Scheffer, G. L., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2003) The formation of vault-tubes: a dynamic interaction between vaults and vault PARP. J. Cell Sci. 116, 4391-4400.
102. Chugani, D. C., Rome, L. H., and Kedersha, N. L. (1993) Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci. 106, 23-29.
103. Dickenson, N. E., Moore, D., Suprenant, K. A., and Dunn, R. C. (2007) Vault ribonucleoprotein particles and the central mass of the nuclear pore complex. Photochem. Photobiol. 83, 686-691.
104. Beck, M., Forster, F., Ecke, M., Plitzko, J. M., Melchior, F., Gerisch, G., Baumeister, W., and Medalia, O. (2004) Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science 306, 1387-1390.
105. Chung, J. H., and Eng, C. (2005) Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res. 65, 8096-8100.
106. Chung, J. H., Ginn-Pease, M. E., and Eng, C. (2005) Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res. 65, 4108-4116.
107. Kitazono, M., Okumura, H., Ikeda, R., Sumizawa, T., Furukawa, T., Nagayama, S., Seto, K., Aikou, T., and Akiyama, S. (2001) Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells. Int. J. Cancer 91, 126-131.
108. Kitazono, M., Sumizawa, T., Takebayashi, Y., Chen, Z. S., Furukawa, T., Nagayama, S., Tani, A., Takao, S., Aikou, T., and Akiyama, S. (1999) Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J. Natl. Cancer Inst. 91, 1647-1653.
109. Stewart, P. L., Makabi, M., Lang, J., Dickey-Sims, C., Robertson, A. J., Coffman, J. A., and Suprenant, K. A. (2005) Sea urchin vault structure, composition, and differential localization during development. BMC Dev. Biol. 5, 3.
110. Luby-Phelps, K., Castle, P. E., Taylor, D. L., and Lanni, F. (1987) Hindered diffusion of inert tracer particles in the cytoplasm of mouse 3T3 cells. Proc. Natl. Acad. Sci. USA 84, 4910-4913.
111. Kaether, C., Skehel, P., and Dotti, C. G. (2000) Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol. Biol. Cell 11, 1213-1224.
112. Li, J. Y., Volknandt, W., Dahlstrom, A., Herrmann, C., Blasi, J., Das, B., and Zimmermann, H. (1999) Axonal transport of ribonucleoprotein particles (vaults). Neuroscience 91, 1055-1065.
113. Herrmann, C., Golkaramnay, E., Inman, E., Rome, L., and Volknandt, W. (1999) Recombinant major vault protein is targeted to neuritic tips of PC12 cells. J. Cell Biol. 144, 1163-1172.
114. Herrmann, C., Volknandt, W., Wittich, B., Kellner, R., and Zimmermann, H. (1996) The major vault protein (MVP100) is contained in cholinergic nerve terminals of electric ray electric organ. J. Biol. Chem. 271, 13908-13915.
115. Kowalski, M. P., Dubouix-Bourandy, A., Bajmoczi, M., Golan, D. E., Zaidi, T., Coutinho-Sledge, Y. S., Gygi, M. P., Gygi, S. P., Wiemer, E. A., and Pier, G. B. (2007) Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 317, 130-132.
116. Eichenmuller, B., Kedersha, N., Solovyeva, E., Everley, P., Lang, J., Himes, R. H., and Suprenant, K. A. (2003) Vaults bind directly to microtubules via their caps and not their barrels. Cell. Motil. Cytoskeleton 56, 225-236.
117. Bouhamyia, L., Chantot-Bastaraud, S., Zaidi, S., Roynard, P., Prengel, C., Bernaudin, J. F., and Fleury-Feith, J. (2007) Immunolocalization and cell expression of lung resistance-related protein (LRP) in normal and tumoral human respiratory cells. J. Histochem. Cytochem. 55, 773-782.
118. Izquierdo, M. A., Scheffer, G. L., Flens, M. J., Giaccone, G., Broxterman, H. J., Meijer, C. J., van derValk, P., and Scheper, R. J. (1996) Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am. J. Pathol. 148, 877-887.
119. Schroeijers, A. B., Siva, A. C., Scheffer, G. L., de Jong, M. C., Bolick, S. C., Dukers, D. F., Slootstra, J. W., Meloen, R. H., Wiemer, E., Kickhoefer, V. A., Rome, L. H., and Scheper, R. J. (2000) The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res. 60, 1104-1110.
120. Meschini, S., Marra, M., Calcabrini, A., Monti, E., Gariboldi, M., Dolfini, E., and Arancia, G. (2002) Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicol. In Vitro 16, 389-398.
121. Herlevsen, M., Oxford, G., Owens, C. R., Conaway, M., and Theodorescu, D. (2007) Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes. Mol. Cancer Ther. 6, 1804-1813.
122. Schroeijers, A. B., Reurs, A. W., Scheffer, G. L., Stam, A. G., de Jong, M. C., Rustemeyer, T., Wiemer, E. A., de Gruijl, T. D., and Scheper, R. J. (2002) Up-regulation of drug resistance-related vaults during dendritic cell development. J. Immunol. 168, 1572-1578.
123. Gopinath, S. C., Matsugami, A., Katahira, M., and Kumar, P. K. (2005) Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound. Nucleic Acids Res. 33, 4874-4881.
124. Siva, A. C., Raval-Fernandes, S., Stephen, A. G., LaFemina, M. J., Scheper, R. J., Kickhoefer, V. A., and Rome, L. H. (2001) Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int. J. Cancer 92, 195-202.
125. van Zon, A., Mossink, M. H., Schoester, M., Scheper, R. J., Sonneveld, P., and Wiemer, E. A. (2004) Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. Cancer Res. 64, 4887-4892.
126. Huffman, K. E., and Corey, D. R. (2005) Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 44, 2253-2261.
127. Gottesman, M. M., Fojo, T., and Bates, S. E. (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48-58.
128. Vasu, S. K., and Rome, L. H. (1995) Dictyostelium vaults: disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein. J. Biol. Chem. 270, 16588-16594.
129. O'Gara, J. P., Gomelsky, M., and Kaplan, S. (1997) Identification and molecular genetic analysis of multiple loci contributing to high-level tellurite resistance in Rhodobacter sphaeroides 2.4.1. Appl. Environ. Microbiol. 63, 4713-4720.
130. Teresi, R. E., Zbuk, K. M., Pezzolesi, M. G., Waite, K. A., and Eng, C. (2007) Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am. J. Hum. Genet. 81, 756-767.
131. Cully, M., You, H., Levine, A. J., and Mak, T. W. (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192.
132. Planchon, S. M., Waite, K. A., and Eng, C. (2008) The nuclear affairs of PTEN. J. Cell Sci. 121, 249-253.
133. Tamguney, T., and Stokoe, D. (2007) New insights into PTEN. J. Cell Sci. 120, 4071-4079.
134. Minaguchi, T., Waite, K. A., and Eng, C. (2006) Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein. Cancer Res. 66, 11677-11682.
135. Eng, C. (2003) PTEN: one gene, many syndromes. Hum. Mutat. 22, 183-198.
136. Aronica, E., Gorter, J. A., Van Vliet, E. A., Spliet, W. G., Van Veelen, C. W., Van Rijen, P. C., Leenstra, S., Ramkema, M. D., Scheffer, G. L., Scheper, R. J., Sisodiya, S. M., and Troost, D. (2003) Overexpression of the Human Major Vault Protein in Gangliogliomas. Epilepsia 44, 1166-1175.
137. Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., and Yin, Y. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157-170.
138. Van Vactor, D., O'Reilly, A. M., and Neel, B. G. (1998) Genetic analysis of protein tyrosine phosphatases. Curr. Opin. Genet. Dev. 8, 112-126.
139. Edouard, T., Montagner, A., Dance, M., Conte, F., Yart, A., Parfait, B., Tauber, M., Salles, J. P., and Raynal, P. (2007) How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms? Cell. Mol. Life Sci. 64, 1585-1590.
140. Shi, Z. Q., Yu, D. H., Park, M., Marshall, M., and Feng, G. S. (2000) Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol. Cell. Biol. 20, 1526-1536.
141. Wu, C. J., O'Rourke, D. M., Feng, G. S., Johnson, G. R., Wang, Q., and Greene, M. I. (2001) The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 20, 6018-6025.
142. McKay, M. M., and Morrison, D. K. (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26, 3113-3121.
143. Yeatman, T. J. (2004) A renaissance for SRC. Nat. Rev. Cancer 4, 470-480.
144. Kopetz, S., Shah, A. N., and Gallick, G. E. (2007) Src continues aging: current and future clinical directions. Clin. Cancer. Res. 13, 7232-7236.
145. Deng, X. W., and Quail, P. H. (1999) Signalling in light-controlled development. Semin. Cell. Dev. Biol. 10, 121-129.
146. Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., Dowd, P., O'Rourke, K., Koeppen, H., and Dixit, V. M. (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92.
147. Wertz, I. E., O'Rourke, K. M., Zhang, Z., Dornan, D., Arnott, D., Deshaies, R. J., and Dixit, V. M. (2004) Human Deetiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303, 1371-1374.
148. Yi, C., Li, S., Wang, J., Wei, N., and Deng, X. W. (2006) Affinity purification reveals the association of WD40 protein constitutive photomorphogenic 1 with the hetero-oligomeric TCP-1 chaperonin complex in mammalian cells. Int. J. Biochem. Cell. Biol. 38, 1076-1083.
149. Ylikomi, T., Bocquel, M. T., Berry, M., Gronemeyer, H., and Chambon, P. (1992) Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. Embo. J. 11, 3681-3694.
150. Beato, M., and Klug, J. (2000) Steroid hormone receptors: an update. Hum. Reprod. Update 6, 225-236.
151. Pestka, S., Krause, C. D., and Walter, M. R. (2004) Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8-32.
152. Reich, N. C. (2007) STAT dynamics. Cytokine Growth Factor Rev. 18, 511-518.
153. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U S A 103, 12481-12486.
154. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C., and Croce, C. M. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci U S A. 103, 2257-2261.
155. Sunnaram, B. L., Gandemer, V., Sebillot, M., Grandgirard, N., Amiot, L., Leray, E., and Goasguen, J. E. (2003) LRP overexpression in monocytic lineage. Leuk. Res. 27, 755-759.
156. Mossink, M. H., De Groot, J., Van Zon, A., Franzel-Luiten, E., Schoester, M., Scheffer, G. L., Sonneveld, P., Scheper, R. J., and Wiemer, E. A. (2003) Unimpaired dendritic cell functions in MVP/LRP knockout mice. Immunology 110, 58-65.
157. Raidl, M., Berger, W., Schulte-Hermann, R., Kandioler-Eckersberger, D.,